SLC16A1 and breast carcinoma: The increase in the expression of these genes in the peripheral blood of the patients may occur due to the presence of circulating tumor cells (CTCs); moreover, our results suggest that MCT1 and CD147—markers that have shown statistical significance—expression in blood samples could be used as a diagnosis marker of breast cancer.